Definitive Guide: Who Qualifies for 340B Program
340B Drug Pricing Program Fundamentals
The 340B drug pricing program was created in 1992 to serve a specific mission: enable covered entities to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
The 340B program achieves its mission by requiring pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs to eligible healthcare organizations at significantly discounted drug prices, often 25-50% below retail.
The program has become a vital financial lifeline for America’s safety net providers, organizations committed to serving patients regardless of their ability to pay. The 340B program, when implemented effectively, allows these organizations to:
- Expand services to vulnerable patient populations
- Offset costs of uncompensated care
- Fund critical community health initiatives
- Maintain financial viability despite slim margins
The savings generated through 340B aren’t simply “nice to have”. They can be essential for survival for organizations serving disadvantaged communities. And the rising pharmaceutical costs and the resulting strain on healthcare budgets make understanding your eligibility for this program more important than ever before.
Covered Entity Eligibility - Who Qualifies?
Federal law limits participation to specific types of organizations called covered entities. HRSA lists the eligible entity types, and they fall into two main categories.
1. Hospitals
To qualify as a hospital, you must generally:
- Be owned or operated by a state/local government OR be a nonprofit hospital with a contract to provide care to low-income patients
- Have specific hospital designations such as:
- Disproportionate share hospitals with a DSH adjustment percentage exceeding 11.75%
- Critical access hospitals serving rural communities
- Sole community hospitals that are the primary hospital in an area with a DSH adjustment percentage above 8%
- Rural referral centers with a DSH adjustment percentage greater than 8%
- Children’s hospitals and free-standing cancer hospitals meeting certain criteria
2. Federal Grantees
- Federally qualified health centers and Look-Alikes
- Ryan White HIV/AIDS Program grantees
- Family planning clinics
- Tuberculosis clinics
- Black Lung clinics
- Native Hawaiian Health Centers
- Urban Indian Organizations
Registration for the program occurs quarterly through the Office of Pharmacy Affairs Information System (340B OPAIS), with specific deadlines for each enrollment period. The Health Resources and Services Administration(HRSA) oversees the program and verification process.
Patient Eligibility Criteria
Patient eligibility is often the most nuanced part of 340B. Insurance status and income do not determine it. The patient’s relationship with the covered entity does.
Three criteria must generally be met:
- The covered entity maintains health records for the individual.
- The provider is employed by the covered entity, or under a contract in which the entity remains responsible for the patient’s care.
- The patient receives services from the covered entity beyond medication dispensing.
Two misconceptions are common. Some assume all uninsured patients qualify. Others assume every prescription from an employed provider is eligible. The deciding factor is a genuine patient-provider relationship, which usually means:
- Electronic or paper records document the patient’s care.
- The patient receives more than prescription services.
- Clinical care is ongoing, not a one-time encounter.
- Services align with the scope of grant funding or hospital services.
For example, a patient receives primary care at your FQHC and is referred to a specialist who prescribes medication. That patient may still qualify if your organization remains responsible for their overall care. A patient who only fills a prescription written by an unaffiliated provider typically would not. HRSA’s eligibility page includes its patient definition guidance.
Balancing Compliance and Access
A strong compliance program protects eligibility. It focuses on two risks: diversion, which means dispensing 340B drugs to ineligible patients, and duplicate discounts, which occur when a drug receives both a 340B discount and a Medicaid rebate. HRSA outlines these expectations in its program requirements.
Effective strategies include:
- Written policies specific to your organization type
- Regular internal audits to identify areas to address before HRSA does
- Accurate identification and flagging of 340B-eligible prescriptions
- Staff training on patient eligibility criteria
- Thorough documentation of patient relationships
Technology can support these efforts through automated eligibility checks, inventory segregation, and reporting. Choose solutions that can adapt as regulations evolve.
Consider patient assistance programs that use 340B savings to provide medications at reduced or no cost to uninsured and underinsured patients. This approach supports the intent of the program and creates community benefits you can document and share with stakeholders.
Compliance is more than avoiding penalties. It builds a sustainable program that can withstand scrutiny while serving more patients.Strategic Implementation For Healthcare Leaders
Healthcare leaders can treat 340B as a strategic asset rather than a tactical obligation. Look beyond eligibility and compliance to how the program supports your financial and clinical goals.
Key considerations include:
- Aligning your 340B strategy with your mission and community needs
- Choosing the right pharmacy model: in-house, contract, or hybrid
- Setting clear metrics to measure program impact
- Creating transparent processes for allocating savings
- Engaging clinical leadership in program decisions
Many organizations reinvest savings in expanded clinical services, care coordination, or technology that improves efficiency. Clear communication helps too. Keep your board, leadership team, and staff informed with regular metric updates and patient impact stories.
When managed well, the program creates a cycle: savings fund expanded services, those services reach more eligible patients, and that can increase savings further.
Moving Forward With Confidence
Understanding who qualifies for the 340B program is just the beginning of a potentially transformative journey for your healthcare organization. The requirements may be complex, but the potential impact, both financial and clinical, makes navigating these complexities worthwhile.
As you evaluate your own organization’s eligibility or work to optimize your existing program, remember that the ultimate measure of success isn’t just compliance or savings generated, it’s the expanded access to care and improved health outcomes for the communities you serve.